{"id":9067,"date":"2018-02-27T11:43:54","date_gmt":"2018-02-27T10:43:54","guid":{"rendered":"https:\/\/udic.es\/?page_id=9067"},"modified":"2023-05-22T11:44:43","modified_gmt":"2023-05-22T09:44:43","slug":"home","status":"publish","type":"page","link":"https:\/\/udic.es\/en\/","title":{"rendered":"Home"},"content":{"rendered":"
The Unitat d’Investigaci\u00f3 Cl\u00ednica (UDIC<\/strong>) was created in 2011 to offer patients an alternative to their unresolved clinical problems, especially in Parkinson’s<\/strong> disease. The beginning is related to the research activity of Dr. Ernest Balaguer<\/strong> at the Hospital Cl\u00ednic<\/strong> de Barcelona (Neurology service Dr. Eduardo Tolosa<\/strong>) in 1987 with a first trial with subcutaneous Lisuride in fluctuating Parkinson’s disease.<\/p>\n Since the incorporation of Dr. Balaguer<\/strong> in the Hospital General de Catalunya<\/strong> in 1990, he began, together with Dr. Soler<\/strong> Singla, the first trials in acute cerebral vascular pathology. Later, research projects in Parkinson’s disease and in Alzheimer’s disease were expanded. The further development of the UDIC<\/strong> and its professionalization has allowed covering other therapeutic areas: neurodegenerative diseases, epilepsy, multiple sclerosis, fragile X syndrome, restless legs syndrome and progressive supranuclear palsy.<\/p>\n At the same time, projects have been carried out on non-neurological lines such as Hematology, Gynecology, Cardiology, Digestive, Infectious and Internal Medicine.<\/p>\n Thus, the UDIC<\/strong> is a multidisciplinary unit with extensive experience in the diagnosis and treatment of neurological and non-neurological diseases, where the care activity and clinical research are perfectly interrelated and integrated. The objective of the UDIC<\/strong> is to contribute to the development of new treatments for diseases with important therapeutic needs, by carrying out clinical trials that follow the standards of Good Clinical Practice, and the applicable legal regulations.<\/p>\n Strict monitoring of the protocols approved by the health authorities is carried out to guarantee the maximum safety of the patients and the best quality of the obtained data.<\/div><\/div>\n